Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales

Group 1 - Blade Ranger Ltd. achieved a first milestone in the sale of its DeepSolar operations to PainReform, resulting in the maturation of zero-exercise-price warrants [1][2] - The agreement completed in March 2025 included common shares of PainReform representing approximately 9.9% of the company's equity and about 3.08 million warrants convertible into common shares [2] - Following the milestone achievement, Blade Ranger received 685,004 warrants exercisable at an exercise price of $0.01 per share, with PainReform's shares trading at approximately $1.91, valuing the warrants at around $2 million [3] Group 2 - The CEO of Blade Ranger stated that the success of PainReform's software sales has improved the company's financial flexibility and supports accelerated business development [4] - The market value of the shares from the matured warrants is approximately NIS 4.5 million based on the current share price [4]